artnet AG: Artnet Data and Analytics show Fine Art in Comparison to other Key Asset Classes
Artnet AG, the leading platform for art market data and media, and the global marketplace for fine art investigates the impact and correlation between inflation, rising oil prices, and the appreciation of investments in fine art. As the global economy experiences unprecedented political turmoil and social upheaval, Artnet data shows significant investments in fine art can be seen as a hedge against inflationary pressures and market volatility.
Over the past few years, and especially in the wake of the pandemic, art has rapidly developed into a viable alternative asset. With over $14 Billion worth of fine art sold at auction last year, a hefty increase in comparison to the $10.1 Billion 2020 total sales, more and more family offices, collectors, and banks are turning to Fine Art as a viable investment.
The Artnet Data Science team can reveal that especially Post War and Contemporary Art are showing strong returns, with data suggesting growth in line with the S&P500. Modern Art and Impressionist Art are on a steady upwards trajectory. Old Master paintings are experiencing more tepid growth.
Artnet will deploy more resources to further develop its AI-supported analytics and business intelligence products. The development of predictive technologies will be instrumental for data-driven decision making, especially in terms of art secured lending, fractionalization, and other financial products.
The top 10 performing artists over the past year, according to Artnet's Database, were Pablo Picasso ($657 Million), Jean-Michel Basquiat ($414 Million), Andy Warhol ($341 Million), Claude Monet ($305 Million), Vincent van Gogh ($235 Million), Gerhard Richter ($225 Million), Banksy ($201 Million), Cy Twombly ($181 Million), Zhang Daqian ($160 Million), and Yayoi Kusama ($146 Million). The NFT breakout artist Beeple is among the top 20 highest grossing artists of 2021.
Artnet ended the year 2021 as its strongest performance ever. A pioneering force in the digitization of the art industry, Artnet's global, highly-curated, and data-driven platform has been critical in supporting the continued growth of the art market.
For more exclusive insights, subscribe to Artnet News Pro, which provides members with decision-driving intelligence about the latest developments in the global art market, from exclusive news and data reports to opinion from our acclaimed columnists.
Learn more and sign up: https://news.artnet.com/subscribe
Further Investor-relations related news and publications can be found here:
http://www.artnet.com/investor-relations/
About Artnet
Artnet has an unparalleled 60 million unique users annually, making it the largest global platform for fine art. Founded in 1989, Artnet has revolutionized the way people discover, research, and collect art today. Artnet's market data is a mission-critical resource for the art industry, encompassing more than 15 million auction results and AI- and ML-driven analytics providing an exceptional level of transparency and insight into the art market. Artnet's marketplace connects leading galleries and auction houses with our global audience, offering a curated selection of over 250,000 artworks for sale worldwide. Artnet Auctions, the pioneering online-only auction platform, offers unprecedented reach, liquidity, and efficiency. Artnet News covers the events, trends, and people shaping the global art market with up-to-the-minute analysis and expert commentary. It is the single most-read news publication in the fine art industry, with a rapidly growing, and dedicated audience. Together, Artnet's broad synergistic product offering provides a comprehensive ecosystem that drives and informs the modern art market.
Artnet AG is listed in the Prime Standard of the Frankfurt Stock Exchange, the segment with the highest transparency standards. The majority of operations are headquartered in New York at its wholly-owned subsidiary, Artnet Worldwide Corporation, a New York based entity founded in 1989. Artnet Worldwide Corp. owns a London based subsidiary, Artnet UK Ltd.
ISIN: DE000A1K0375
LEI: 391200SHGPEDTRIC0X31
Language: |
English |
Company: |
artnet AG |
Oranienstraße 164 |
|
10969 Berlin |
|
Germany |
|
Phone: |
+49 (0)30 20 91 78 -0 |
Fax: |
+49 (0)30 20 91 78 -29 |
E-mail: |
|
Internet: |
|
ISIN: |
DE000A1K0375 |
WKN: |
A1K037 |
Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Stuttgart, Tradegate Exchange |
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220228005511/en/
Contact information
Jacob Pabst
Tel: 030 20 91 78 20
Email:ir@artnet.com,
Sophie Neuendorf
Vice President
sneuendorf@artnet.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Logo Established for the “Japan Creator Support Fund” to Support the Global Success of Japan’s Next-Generation Creators and Artists30.6.2025 09:00:00 EEST | Press release
The Japan Arts Council (President: Mariko Hasegawa), with funding from the Agency for Cultural Affairs, has established the Japan Creator Support Fund to support projects nurturing Japan’s diverse creators and artists, and to support cultural facilities’ function enhancement. We are pleased to announce that the logo for the Fund has been established and that the English-language global website, which is promoting this project overseas, has been officially launched on Monday, June 30, 2025. A promotional video for international audiences is also now available on the website. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627404244/en/ From the top left are the individual logos for the following support programs: the Creator & Artist Development Support Program [FOR CREATORS], the Support Program for Cultural Facilities Function Enhancement [FOR CULTURAL FACILITIES], the Creator Support Program (Program Development & Implem
From Waste to Strategic Metals: Circular Materials Achieves First Industrial-Scale Recoveries Under the Critical Raw Materials Act30.6.2025 09:00:00 EEST | Press release
Circular Materials announces two major milestones under the Critical Raw Materials Act: the recovery from industrial wastewater of the first kilogram of ruthenium and the first ton of nickel, preventing the release of heavy metals into the environment. These results were secured through strong collaborations with two leading companies in surface treatments: LEM, core company of the LEM INDUSTRIES Group, specialized in the luxury sector, and Argos Surface Technologies Group, a leader in industrial coatings. This success comes just a few months after the European Commission recognized Recover-IT as a strategic project, confirming the pivotal role of Circular Materials in securing critical raw material supplies, increasing recycling, and reducing the EU’s dependence on imports. Ruthenium and Nickel: crucial metals for a sustainable future Ruthenium, a noble metal from the platinum group, is essential for cutting-edge sectors such as advanced electronics, green hydrogen production, fine ch
SBC Medical added to membership of Russell 3000 ® Index28.6.2025 02:30:00 EEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 23:44:00 EEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 17:00:00 EEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom